NasdaqGS - Delayed Quote USD

Sight Sciences, Inc. (SGHT)

4.0600
-0.1400
(-3.33%)
At close: June 9 at 4:00:00 PM EDT
Loading Chart for SGHT
  • Previous Close 4.2000
  • Open 4.2500
  • Bid 4.0200 x 100
  • Ask 4.1000 x 100
  • Day's Range 3.9101 - 4.2500
  • 52 Week Range 2.0300 - 8.4500
  • Volume 213,839
  • Avg. Volume 198,652
  • Market Cap (intraday) 209.911M
  • Beta (5Y Monthly) 2.45
  • PE Ratio (TTM) --
  • EPS (TTM) -0.9800
  • Earnings Date Jul 30, 2025 - Aug 4, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 3.68

Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases. The company operates in two segments, Surgical Glaucoma and Dry Eye. Its products include OMNI surgical system, an implant-free, handheld, single-use, therapeutic technology that enables ophthalmic surgeons to perform a comprehensive procedure indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma, as well as for the catheterization and transluminal viscodilation of Schlemm's canal and cutting of the trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma; and SION surgical instrument, a bladeless manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The company also provides TearCare system, a dry eye device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.

www.sightsciences.com

216

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SGHT

View More

Performance Overview: SGHT

Trailing total returns as of 6/9/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

SGHT
11.54%
S&P 500 (^GSPC)
2.11%

1-Year Return

SGHT
40.82%
S&P 500 (^GSPC)
12.32%

3-Year Return

SGHT
61.41%
S&P 500 (^GSPC)
49.48%

5-Year Return

SGHT
86.47%
S&P 500 (^GSPC)
87.26%

Compare To: SGHT

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SGHT

View More

Valuation Measures

Annual
As of 6/9/2025
  • Market Cap

    209.91M

  • Enterprise Value

    141.61M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.63

  • Price/Book (mrq)

    2.70

  • Enterprise Value/Revenue

    1.81

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -63.24%

  • Return on Assets (ttm)

    -21.77%

  • Return on Equity (ttm)

    -52.88%

  • Revenue (ttm)

    78.11M

  • Net Income Avi to Common (ttm)

    -49.4M

  • Diluted EPS (ttm)

    -0.9800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    108.77M

  • Total Debt/Equity (mrq)

    52.12%

  • Levered Free Cash Flow (ttm)

    -8.84M

Research Analysis: SGHT

View More

Company Insights: SGHT

Research Reports: SGHT

View More

People Also Watch